Joel Blanchard

About Joel Blanchard

Joel Blanchard, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at Massachusetts Institute of Technology,

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson’s disease

Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model

Comparative study of enriched dopaminergic neurons from siblings with Gaucher disease discordant for parkinsonism

Secretome analysis of APOE3 and APOE4 iPSC‐derived mural cells indicates TGFβ as potential key player in blood‐brain barrier alterations

Investigating the role of ketogenic conditions on cholesterol metabolism and neuroinflammation in APOE4 carriers

APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease

Joel Blanchard Information

University

Position

___

Citations(all)

1931

Citations(since 2020)

939

Cited By

1272

hIndex(all)

14

hIndex(since 2020)

14

i10Index(all)

15

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Top articles of Joel Blanchard

Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson’s disease

Science advances

2024/1/10

Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model

Nature Communications

2024/1/10

Comparative study of enriched dopaminergic neurons from siblings with Gaucher disease discordant for parkinsonism

bioRxiv

2024

Secretome analysis of APOE3 and APOE4 iPSC‐derived mural cells indicates TGFβ as potential key player in blood‐brain barrier alterations

Alzheimer's & Dementia

2023/12

Joel Blanchard
Joel Blanchard

H-Index: 9

Investigating the role of ketogenic conditions on cholesterol metabolism and neuroinflammation in APOE4 carriers

Alzheimer's & Dementia

2023/12

Camille Goldman
Camille Goldman

H-Index: 1

Joel Blanchard
Joel Blanchard

H-Index: 9

APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes

Alzheimer's & Dementia

2023/12

Joel Blanchard
Joel Blanchard

H-Index: 9

Manolis Kellis
Manolis Kellis

H-Index: 111

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

JoVE (Journal of Visualized Experiments)

2023/10/20

Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease

JoVE (Journal of Visualized Experiments)

2023/10/20

Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity

iScience

2023/9/15

Modeling the blood-brain barrier using human-induced pluripotent stem cells

2023/6/11

Understanding human biology with iPSC derived cell types in the Era of CRISPR technology

Frontiers in Cell and Developmental Biology

2023

Engineered 3D immuno-glial-neurovascular human brain model

bioRxiv

2023

Understanding molecular and cellular mechanisms of APOE4‐mediated susceptibility to tau‐related cognitive impairments in the miBrain model

Alzheimer's & Dementia

2023/12

Camille Goldman
Camille Goldman

H-Index: 1

Joel Blanchard
Joel Blanchard

H-Index: 9

Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies

PloS one

2022/12/1

Small molecule suppressors of apoe gene expression and cerebral vascular amyloid pathology

2022/9/15

Apoe4 impairs myelination via altered cholesterol biosynthesis and transport in oligodendroglia

2022/9/15

Multicellular integrated brain tissue in neurological diseases

2022/4/28

Dissecting the complexities of Alzheimer disease with in vitro models of the human brain

2022/1

Proteomic profiling dataset of chemical perturbations in multiple biological backgrounds

Scientific Data

2021/8/25

Gamma frequency sensory stimulation in probable mild Alzheimer’s dementia patients: results of a preliminary clinical trial

2021/3/3

See List of Professors in Joel Blanchard University(Massachusetts Institute of Technology)